Solvanix Pty Ltd Information

Solvanix is a biotechnology company with a novel technology for improving stability and reducing the aggregation of fully human antibodies. Traditional monoclonal and fragment antibodies can have limited stability and a tendency to aggregate, which greatly impacts manufacturability, formulation and product quality. Solvanix' proprietary StAbilize™ technology works by boosting stability and reducing aggregation of monoclonal antibodies, antibody fragments and bi-specifics. The Company is working with its biotech and pharma partners to improve their therapeutic antibodies and is providing licenses to the StAbilize™ technology.